Related references
Note: Only part of the references are listed.Vomocytosis: What we know so far
Paula I. Seoane et al.
CELLULAR MICROBIOLOGY (2020)
Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp.
Suelen Andreia Rossi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii
Vanessa K. A. Silva et al.
MEDICAL MYCOLOGY (2020)
Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa
Tao Chen et al.
CLINICAL INFECTIOUS DISEASES (2019)
A Novel Protocol for the Isolation of Fungal Extracellular Vesicles Reveals the Participation of a Putative Scramblase in Polysaccharide Export and Capsule Construction in Cryptococcus gattii
Flavia C. G. Reis et al.
MSPHERE (2019)
Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris
Haroldo Cesar de Oliveira et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study
Juan Carlos Hurtado et al.
SCIENTIFIC REPORTS (2019)
Mortality by cryptococcosis in Brazil from 2000 to 2012 A descriptive epidemiological study
Emmanuel Alves Soares et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
New Insights Into Cryptococcus Spp. Biology and Cryptococcal Meningitis
Elvis Temfack et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2019)
Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials
Franciele Aline Bruinsmann et al.
MOLECULES (2019)
Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease
Gemma L. Nixon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Mechanism of intranasal drug delivery directly to the brain
Tyler P. Crowe et al.
LIFE SCIENCES (2018)
Cost-effectiveness of amphotericin B formulations in the treatment of systemic fungal infections
Helena Hiemisch Lobo Borba et al.
MYCOSES (2018)
The novel microtubule-associated CAP-glycine protein Cgp1 governs growth, differentiation, and virulence of Cryptococcus neoformans
Li Li Wang et al.
VIRULENCE (2018)
Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis
Megan Truong et al.
PEERJ (2018)
Drug metabolism in drug discovery and development
Zhoupeng Zhang et al.
ACTA PHARMACEUTICA SINICA B (2018)
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
Radha Rajasingham et al.
LANCET INFECTIOUS DISEASES (2017)
A cell impedance-based real-time in vitro assay to assess the toxicity of amphotericin B formulations
Jean Menotti et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
The Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against Cryptococcus neoformans
Luna S. Joffe et al.
FRONTIERS IN MICROBIOLOGY (2017)
SynergyFinder: a web application for analyzing drug combination dose-response matrix data
Aleksandr Ianevski et al.
BIOINFORMATICS (2017)
Benzimidazole resistance in helminths: From problem to diagnosis
Luis Fernando et al.
ACTA TROPICA (2016)
EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents
M. C. Arendrup et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Cryptococcus neoformans Intracellular Proliferation and Capsule Size Determines Early Macrophage Control of Infection
Aleksandra Bojarczuk et al.
SCIENTIFIC REPORTS (2016)
Microtubules and Actin Cytoskeleton of Cryptococcus neoformans as Targets for Anticancer Agents to Potentiate a Novel Approach for New Antifungals
Marie Kopecka
CHEMOTHERAPY (2015)
Toward improved anti-cryptococcal drugs: Novel molecules and repurposed drugs
Damian J. Krysan
FUNGAL GENETICS AND BIOLOGY (2015)
Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis
Wilber Sabiiti et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
A New Bliss Independence Model to Analyze Drug Combination Data
Wei Zhao et al.
JOURNAL OF BIOMOLECULAR SCREENING (2014)
Cryptococcus interactions with macrophages: evasion and manipulation of the phagosome by a fungal pathogen
Simon A. Johnston et al.
CELLULAR MICROBIOLOGY (2013)
Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans
Rocio Garcia-Rodas et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Dynamics of Cryptococcus neoformans-Macrophage Interactions Reveal that Fungal Background Influences Outcome during Cryptococcal Meningoencephalitis in Humans
Alexandre Alanio et al.
MBIO (2011)
Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro-In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatus
Joseph Meletiadis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pharmacokinetics and pharmacodynamics of nasally delivered midazolam
Manuel Haschke et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2010)
Automated Analysis of Cryptococcal Macrophage Parasitism Using GFP-Tagged Cryptococci
Kerstin Voelz et al.
PLOS ONE (2010)
Estimation of the cost of large-scale school deworming programmes with benzimidazoles
A. Montresor et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2010)
Phagosorne extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages
Mauricio Alvarez et al.
CURRENT BIOLOGY (2006)
Structural basis for the regulation of tubulin by vinblastine
B Gigant et al.
NATURE (2005)
Pharmacokinetics of fenbendazole following intravenous and oral administration to pigs
MB Petersen et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2000)
Share Paper
